Logo image of BTSGU

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) Stock Fundamental Analysis

NASDAQ:BTSGU - Nasdaq - US10950A2050 - Currency: USD

76.06  -0.52 (-0.68%)

After market: 76.06 0 (0%)

Fundamental Rating

4

Overall BTSGU gets a fundamental rating of 4 out of 10. We evaluated BTSGU against 102 industry peers in the Health Care Providers & Services industry. BTSGU has only an average score on both its financial health and profitability. While showing a medium growth rate, BTSGU is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BTSGU had positive earnings in the past year.
In the past year BTSGU had a positive cash flow from operations.
In multiple years BTSGU reported negative net income over the last 5 years.
Of the past 5 years BTSGU 4 years had a positive operating cash flow.
BTSGU Yearly Net Income VS EBIT VS OCF VS FCFBTSGU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

With a Return On Assets value of 0.98%, BTSGU perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
BTSGU has a Return On Equity (3.39%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 4.48%, BTSGU is in line with its industry, outperforming 51.96% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BTSGU is significantly below the industry average of 9.62%.
The last Return On Invested Capital (4.48%) for BTSGU is above the 3 year average (3.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROIC 4.48%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSGU Yearly ROA, ROE, ROICBTSGU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 0.49%, BTSGU is in line with its industry, outperforming 50.00% of the companies in the same industry.
BTSGU has a Operating Margin of 2.15%. This is comparable to the rest of the industry: BTSGU outperforms 48.04% of its industry peers.
BTSGU's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 13.46%, BTSGU is not doing good in the industry: 69.61% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BTSGU has declined.
Industry RankSector Rank
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSGU Yearly Profit, Operating, Gross MarginsBTSGU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

4

2. Health

2.1 Basic Checks

BTSGU has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BTSGU has been increased compared to 1 year ago.
Compared to 5 years ago, BTSGU has more shares outstanding
The debt/assets ratio for BTSGU has been reduced compared to a year ago.
BTSGU Yearly Shares OutstandingBTSGU Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSGU Yearly Total Debt VS Total AssetsBTSGU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 4.20 indicates that BTSGU is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.20, BTSGU is doing good in the industry, outperforming 77.45% of the companies in the same industry.
BTSGU has a debt to FCF ratio of 19.98. This is a negative value and a sign of low solvency as BTSGU would need 19.98 years to pay back of all of its debts.
BTSGU has a Debt to FCF ratio of 19.98. This is comparable to the rest of the industry: BTSGU outperforms 40.20% of its industry peers.
BTSGU has a Debt/Equity ratio of 1.48. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.48, BTSGU is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Altman-Z 4.2
ROIC/WACC0.53
WACC8.39%
BTSGU Yearly LT Debt VS Equity VS FCFBTSGU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

BTSGU has a Current Ratio of 1.73. This is a normal value and indicates that BTSGU is financially healthy and should not expect problems in meeting its short term obligations.
BTSGU has a Current ratio of 1.73. This is in the better half of the industry: BTSGU outperforms 62.75% of its industry peers.
A Quick Ratio of 1.37 indicates that BTSGU should not have too much problems paying its short term obligations.
BTSGU's Quick ratio of 1.37 is in line compared to the rest of the industry. BTSGU outperforms 51.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.37
BTSGU Yearly Current Assets VS Current LiabilitesBTSGU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

BTSGU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 122.31%, which is quite impressive.
Looking at the last year, BTSGU shows a small growth in Revenue. The Revenue has grown by 1.45% in the last year.
BTSGU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.01% yearly.
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%

3.2 Future

The Earnings Per Share is expected to grow by 29.97% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 7.63% on average over the next years.
EPS Next Y49.38%
EPS Next 2Y33.62%
EPS Next 3Y28.91%
EPS Next 5Y29.97%
Revenue Next Year9.66%
Revenue Next 2Y10.77%
Revenue Next 3Y10.94%
Revenue Next 5Y7.63%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BTSGU Yearly Revenue VS EstimatesBTSGU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
BTSGU Yearly EPS VS EstimatesBTSGU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 122.68, which means the current valuation is very expensive for BTSGU.
Compared to the rest of the industry, the Price/Earnings ratio of BTSGU is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.60, BTSGU is valued quite expensively.
Based on the Price/Forward Earnings ratio of 77.46, the valuation of BTSGU can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BTSGU indicates a slightly more expensive valuation: BTSGU is more expensive than 60.78% of the companies listed in the same industry.
BTSGU is valuated expensively when we compare the Price/Forward Earnings ratio to 22.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 122.68
Fwd PE 77.46
BTSGU Price Earnings VS Forward Price EarningsBTSGU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

BTSGU's Enterprise Value to EBITDA ratio is in line with the industry average.
BTSGU's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 103.95
EV/EBITDA 35.25
BTSGU Per share dataBTSGU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BTSGU's earnings are expected to grow with 28.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.48
PEG (5Y)N/A
EPS Next 2Y33.62%
EPS Next 3Y28.91%

4

5. Dividend

5.1 Amount

BTSGU has a Yearly Dividend Yield of 4.01%, which is a nice return.
Compared to an average industry Dividend Yield of 2.46, BTSGU pays a better dividend. On top of this BTSGU pays more dividend than 98.04% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, BTSGU pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.01%

5.2 History

BTSGU is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BTSGU Yearly Dividends per shareBTSGU Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

DPN/A
EPS Next 2Y33.62%
EPS Next 3Y28.91%
BTSGU Yearly Income VS Free CF VS DividendBTSGU Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27

NASDAQ:BTSGU (6/12/2025, 8:00:02 PM)

After market: 76.06 0 (0%)

76.06

-0.52 (-0.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners46.78%
Inst Owner ChangeN/A
Ins Owners0.56%
Ins Owner ChangeN/A
Market Cap13.25B
Analysts84.44
Price Target96.44 (26.79%)
Short Float %0.01%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield 4.01%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date04-15 2025-04-15 (0.8437)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)47.16%
Min EPS beat(2)-2.7%
Max EPS beat(2)97.01%
EPS beat(4)1
Avg EPS beat(4)3.84%
Min EPS beat(4)-40.94%
Max EPS beat(4)97.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.12%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)2.86%
Revenue beat(4)3
Avg Revenue beat(4)2.37%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)4.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.42%
PT rev (3m)9.82%
EPS NQ rev (1m)13.33%
EPS NQ rev (3m)9.58%
EPS NY rev (1m)40.59%
EPS NY rev (3m)25.93%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)2.43%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)2.74%
Valuation
Industry RankSector Rank
PE 122.68
Fwd PE 77.46
P/S 1.15
P/FCF 103.95
P/OCF 64.89
P/B 7.85
P/tB N/A
EV/EBITDA 35.25
EPS(TTM)0.62
EY0.82%
EPS(NY)0.98
Fwd EY1.29%
FCF(TTM)0.73
FCFY0.96%
OCF(TTM)1.17
OCFY1.54%
SpS66.39
BVpS9.68
TBVpS-7.18
PEG (NY)2.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROCE 5.67%
ROIC 4.48%
ROICexc 4.54%
ROICexgc 14.07%
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
FCFM 1.1%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexcg growth 3Y-9.4%
ROICexcg growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score6
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Debt/EBITDA 5.59
Cap/Depr 38.81%
Cap/Sales 0.66%
Interest Coverage 1.22
Cash Conversion 45.71%
Profit Quality 222.79%
Current Ratio 1.73
Quick Ratio 1.37
Altman-Z 4.2
F-Score6
WACC8.39%
ROIC/WACC0.53
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
EPS Next Y49.38%
EPS Next 2Y33.62%
EPS Next 3Y28.91%
EPS Next 5Y29.97%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%
Revenue Next Year9.66%
Revenue Next 2Y10.77%
Revenue Next 3Y10.94%
Revenue Next 5Y7.63%
EBIT growth 1Y60.42%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year54.27%
EBIT Next 3Y23.8%
EBIT Next 5YN/A
FCF growth 1Y-141.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.72%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%